Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Celldex Therapeutics Inc.

    NASDAQ: CLDX · Real-Time Price · USD
    20.46
    -0.71 (-3.35%)
    At close: Jun 27, 2025, 2:32 PM

    Celldex Therapeutics Statistics

    Share Statistics

    Celldex Therapeutics has 66.39M shares outstanding. The number of shares has increased by 0.72% in one year.

    Shares Outstanding

    n/a
    		 66.39M

    Shares Change (YoY)

    n/a
    		 0.72%

    Shares Change (QoQ)

    n/a
    		 0.06%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 64.51M

    Failed to Deliver (FTD) Shares

    n/a
    		 36

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 8.37M, so 12.61% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 8.37M

    Short % of Shares Out

    n/a
    		 12.61%

    Short % of Float

    n/a
    		 14.9%

    Short Ratio (days to cover)

    n/a
    		 7.68

    Valuation Ratios

    The PE ratio is -10.31 and the forward PE ratio is -5.35. Celldex Therapeutics's PEG ratio is 0.64.

    PE Ratio

    n/a
    		 -10.31

    Forward PE

    n/a
    		 -5.35

    PS Ratio

    n/a
    		 231.8

    Forward PS

    n/a
    		 1.9

    PB Ratio

    n/a
    		 2.18

    P/FCF Ratio

    n/a
    		 -10.19

    PEG Ratio

    n/a
    		 0.64
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Celldex Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 18.91, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 18.91

    Quick Ratio

    n/a
    		 18.91

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $37,741.94

    Profits Per Employee

    n/a
    		 $-848,725.81

    Employee Count

    n/a
    		 186

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -43.8% in the last 52 weeks. The beta is 1.14, so Celldex Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.14

    52-Week Price Change

    n/a
    		 -43.8%

    50-Day Moving Average

    n/a
    		 20.02

    200-Day Moving Average

    n/a
    		 24.42

    Relative Strength Index (RSI)

    n/a
    		 55.2

    Average Volume (20 Days)

    n/a
    		 949,933

    Income Statement

    In the last 12 months, Celldex Therapeutics had revenue of 7.02M and earned -157.86M in profits. Earnings per share was -2.45.

    Revenue

    n/a
    		 7.02M

    Gross Profit

    n/a
    		 7.02M

    Operating Income

    n/a
    		 -195.08M

    Net Income

    n/a
    		 -157.86M

    EBITDA

    n/a
    		 -191.9M

    EBIT

    n/a
    		 -195.08M

    Earnings Per Share (EPS)

    n/a
    		 -2.45
    Full Income Statement

    Balance Sheet

    The company has 28.36M in cash and 3.81M in debt, giving a net cash position of 24.54M.

    Cash & Cash Equivalents

    n/a
    		 28.36M

    Total Debt

    n/a
    		 3.81M

    Net Cash

    n/a
    		 24.54M

    Retained Earnings

    n/a
    		 -1.56B

    Total Assets

    n/a
    		 739.47M

    Working Capital

    n/a
    		 661.74M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -157.78M and capital expenditures -1.92M, giving a free cash flow of -159.7M.

    Operating Cash Flow

    n/a
    		 -157.78M

    Capital Expenditures

    n/a
    		 -1.92M

    Free Cash Flow

    n/a
    		 -159.7M

    FCF Per Share

    n/a
    		 -2.48
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -2778.89% and -2248.76%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -2778.89%

    Pretax Margin

    n/a
    		 -2248.76%

    Profit Margin

    n/a
    		 -2248.76%

    EBITDA Margin

    n/a
    		 -2733.63%

    EBIT Margin

    n/a
    		 -2778.89%

    FCF Margin

    n/a
    		 -2274.89%

    Dividends & Yields

    CLDX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CLDX is $46.5, which is 119.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $46.5

    Price Target Difference

    n/a
    		 119.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 11, 2019. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Feb 11, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 17.44

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist